Harriet Corvol

Summary

Country: France

Publications

  1. doi request reprint [Why use long-term macrolide therapy in pediatric pulmonology?]
    H Corvol
    Service de pneumologie pédiatrique, Hopital Trousseau, AP HP, Centre de Ressources et de Compétences pour la Mucoviscidose, Centre de reference des maladies respiratoires rares, Universite Pierre et Marie Curie Paris 6, unité Inserm U938, 26, avenue du Dr Netter, 75012 Paris, France Electronic address
    Arch Pediatr 21:314-21. 2014
  2. pmc New insights into pediatric idiopathic pulmonary hemosiderosis: the French RespiRare(®) cohort
    Jessica Taytard
    Pediatric Pulmonary Department, AP HP, Hopital Trousseau, Universite Pierre et Marie Curie PARIS6, Inserm U938, 26, avenue du Docteur Arnold Netter, 75012 Paris, France
    Orphanet J Rare Dis 8:161. 2013
  3. doi request reprint Ancestral haplotype 8.1 and lung disease severity in European cystic fibrosis patients
    Harriet Corvol
    AP HP, Hopital Trousseau, Pediatric Pulmonary Department, Inserm U938, Paris, France
    J Cyst Fibros 11:63-7. 2012
  4. pmc Longitudinal survey of Staphylococcus aureus in cystic fibrosis patients using a multiple-locus variable-number of tandem-repeats analysis method
    Hoang Vu-Thien
    Universite Paris Sud 11, CNRS, UMR 8621, Institut de Genetique et Microbiologie, Orsay 91405, France
    BMC Microbiol 10:24. 2010
  5. pmc Glucocorticoid receptor gene polymorphisms associated with progression of lung disease in young patients with cystic fibrosis
    Harriet Corvol
    Universite Pierre et Marie Curie PARIS6, Paris, 75571 France
    Respir Res 8:88. 2007
  6. doi request reprint Pharmacogenetic response to albuterol among asthmatics
    Harriet Corvol
    UCSF Lung Biology Center, University of California, San Francisco, CA 94143 2911, USA
    Pharmacogenomics 9:505-10. 2008
  7. doi request reprint Genetic variations in inflammatory mediators influence lung disease progression in cystic fibrosis
    Harriet Corvol
    AP HP, Hopital Trousseau, Pediatric Pulmonary Department, Paris, France
    Pediatr Pulmonol 43:1224-32. 2008
  8. pmc Genetic ancestry modifies pharmacogenetic gene-gene interaction for asthma
    Harriet Corvol
    Department of Biopharmaceutical Sciences, University of California, San Francisco, California, USA
    Pharmacogenet Genomics 19:489-96. 2009
  9. ncbi request reprint Influence of interleukin-10 on Aspergillus fumigatus infection in patients with cystic fibrosis
    Jacques Brouard
    Inserm E213, Armand Trousseau Hospital, Paris, and the Department of Pediatrics, Georges Clemenceau Hospital, Caen, France
    J Infect Dis 191:1988-91. 2005
  10. pmc AGER -429T/C is associated with an increased lung disease severity in cystic fibrosis
    Julie Beucher
    AP HP, Hopital Trousseau, Pediatric Pulmonary Department, Inserm U938, Paris, France
    PLoS ONE 7:e41913. 2012

Collaborators

Detail Information

Publications22

  1. doi request reprint [Why use long-term macrolide therapy in pediatric pulmonology?]
    H Corvol
    Service de pneumologie pédiatrique, Hopital Trousseau, AP HP, Centre de Ressources et de Compétences pour la Mucoviscidose, Centre de reference des maladies respiratoires rares, Universite Pierre et Marie Curie Paris 6, unité Inserm U938, 26, avenue du Dr Netter, 75012 Paris, France Electronic address
    Arch Pediatr 21:314-21. 2014
    ..It also provides new insights on the potential effects of macrolides on diffuse parenchymal lung diseases. ..
  2. pmc New insights into pediatric idiopathic pulmonary hemosiderosis: the French RespiRare(®) cohort
    Jessica Taytard
    Pediatric Pulmonary Department, AP HP, Hopital Trousseau, Universite Pierre et Marie Curie PARIS6, Inserm U938, 26, avenue du Docteur Arnold Netter, 75012 Paris, France
    Orphanet J Rare Dis 8:161. 2013
    ..We present the French pediatric cohort of IPH collected through the French Reference Center for Rare Lung Diseases (RespiRare®, http://www.respirare.fr)...
  3. doi request reprint Ancestral haplotype 8.1 and lung disease severity in European cystic fibrosis patients
    Harriet Corvol
    AP HP, Hopital Trousseau, Pediatric Pulmonary Department, Inserm U938, Paris, France
    J Cyst Fibros 11:63-7. 2012
    ..As inflammation is a key component inducing CF lung damage, we investigated whether the 8.1AH represents a lung function modifier in CF...
  4. pmc Longitudinal survey of Staphylococcus aureus in cystic fibrosis patients using a multiple-locus variable-number of tandem-repeats analysis method
    Hoang Vu-Thien
    Universite Paris Sud 11, CNRS, UMR 8621, Institut de Genetique et Microbiologie, Orsay 91405, France
    BMC Microbiol 10:24. 2010
    ..Multiple-locus variable-number tandem repeat analysis (MLVA/VNTR) was used to survey S. aureus clinical isolates in a French paediatric CF centre...
  5. pmc Glucocorticoid receptor gene polymorphisms associated with progression of lung disease in young patients with cystic fibrosis
    Harriet Corvol
    Universite Pierre et Marie Curie PARIS6, Paris, 75571 France
    Respir Res 8:88. 2007
    ....
  6. doi request reprint Pharmacogenetic response to albuterol among asthmatics
    Harriet Corvol
    UCSF Lung Biology Center, University of California, San Francisco, CA 94143 2911, USA
    Pharmacogenomics 9:505-10. 2008
    ..Herein, we focus on pharmacogenetic associations between genetic variants in the beta(2)-adrenergic receptor gene and bronchodilator response to albuterol among subjects with asthma...
  7. doi request reprint Genetic variations in inflammatory mediators influence lung disease progression in cystic fibrosis
    Harriet Corvol
    AP HP, Hopital Trousseau, Pediatric Pulmonary Department, Paris, France
    Pediatr Pulmonol 43:1224-32. 2008
    ..These findings support the concept that TGFB1 gene variants appear to be important genetic modifiers of lung disease progression in CF...
  8. pmc Genetic ancestry modifies pharmacogenetic gene-gene interaction for asthma
    Harriet Corvol
    Department of Biopharmaceutical Sciences, University of California, San Francisco, California, USA
    Pharmacogenet Genomics 19:489-96. 2009
    ..Therefore, we reasoned that interactions between the IL6 and IL6R genes might be associated with bronchodilator drug responsiveness to albuterol in asthmatic patients...
  9. ncbi request reprint Influence of interleukin-10 on Aspergillus fumigatus infection in patients with cystic fibrosis
    Jacques Brouard
    Inserm E213, Armand Trousseau Hospital, Paris, and the Department of Pediatrics, Georges Clemenceau Hospital, Caen, France
    J Infect Dis 191:1988-91. 2005
    ..fumigatus. These results suggest that polymorphisms in the promoter region of the IL-10 gene may influence the host response to A. fumigatus in the context of CF...
  10. pmc AGER -429T/C is associated with an increased lung disease severity in cystic fibrosis
    Julie Beucher
    AP HP, Hopital Trousseau, Pediatric Pulmonary Department, Inserm U938, Paris, France
    PLoS ONE 7:e41913. 2012
    ..The functional promoter AGER -429C variant is associated with an increased RAGE expression that can lead to an increased lung inflammation and a more severe lung disease...
  11. ncbi request reprint Distinct cytokine production by lung and blood neutrophils from children with cystic fibrosis
    Harriet Corvol
    Departement de Pneumologie Pediatrique Institut National de la Santé et de la Recherche Médicale E213, Hopital Armand Trousseau, 75012 Paris, France
    Am J Physiol Lung Cell Mol Physiol 284:L997-1003. 2003
    ..They provide support to the hypothesis that not only the CF genotype but also the local environment may modify the functional properties of the neutrophils...
  12. pmc Neutrophils in cystic fibrosis display a distinct gene expression pattern
    Minou Adib-Conquy
    Unit Cytokines and Inflammation, Institut Pasteur, Paris, France
    Mol Med 14:36-44. 2008
    ..Altogether, this study clearly demonstrates that blood PMNs from CF patients display a profound modification of gene expression profile associated with the disease, suggesting a state of activation of these cells...
  13. doi request reprint Macrolides: new therapeutic perspectives in lung diseases
    Loic Guillot
    Inserm U938, Paris F 75012, France
    Int J Biochem Cell Biol 43:1241-6. 2011
    ..It also discusses novel findings which suggest that macrolides may contribute to alveolar surfactant homeostasis...
  14. pmc Interstitial lung diseases in children
    Annick Clement
    Pediatric Pulmonary Department, Reference Center for Rare Lung Diseases, AP HP, Hopital Trousseau, INSERM UMR S 938, Universite Pierre et Marie Curie Paris 6, Paris, F 75012 France
    Orphanet J Rare Dis 5:22. 2010
    ..An overall favorable response to corticosteroid therapy is observed in around 50% of cases, often associated with sequelae such as limited exercise tolerance or the need for long-term oxygen therapy...
  15. pmc A national internet-linked based database for pediatric interstitial lung diseases: the French network
    Nadia Nathan
    AP HP, Hopital Trousseau, Pediatric Pulmonary Department, Paris, France
    Orphanet J Rare Dis 7:40. 2012
    ..After the launch of the French Reference Centre for Rare Lung Diseases (RespiRare®), we created a national network and a web-linked database to collect data on pediatric ILD...
  16. pmc Multiple-locus variable-number tandem-repeat analysis for longitudinal survey of sources of Pseudomonas aeruginosa infection in cystic fibrosis patients
    Hoang Vu-Thien
    Bacteriologie, Hopital Armand Trousseau, INSERM URM S 719, Paris, France
    J Clin Microbiol 45:3175-83. 2007
    ..aeruginosa infection. The resulting data and strain genetic profiles can be queried on http://bacterial-genotyping.igmors.u-psud.fr...
  17. doi request reprint Anoctamin 1 dysregulation alters bronchial epithelial repair in cystic fibrosis
    Manon Ruffin
    INSERM, U938, 34 rue Crozatier, 75012 Paris, France UPMC, University of Paris 06, 4 place Jussieu, 75005 Paris, France
    Biochim Biophys Acta 1832:2340-51. 2013
    ..In summary, our study demonstrates involvement of ANO1 decreased activity and expression in abnormal CF airway epithelial repair and suggests that ANO1 correction may improve this process. ..
  18. pmc Reference percentiles for FEV(1) and BMI in European children and adults with cystic fibrosis
    Pierre Yves Boelle
    AP HP, Hôpital Trousseau Pediatric Pulmonary Department, Hopital St Antoine Public Health Department, Paris, France
    Orphanet J Rare Dis 7:64. 2012
    ..Here, we used a large database of European CF patients to compute CF specific reference equations for FEV(1) and BMI, derived CF-specific percentile charts and compared these European data to their nearest international equivalents...
  19. doi request reprint HRCT and MRI of the lung in children with cystic fibrosis: comparison of different scoring systems
    Chiara Sileo
    AP HP, Hopital Trousseau, Pediatric Radiology Department, Paris, France Université Pierre et Marie Curie Paris 6, Paris, France
    J Cyst Fibros 13:198-204. 2014
    ....
  20. doi request reprint Lung alveolar epithelium and interstitial lung disease
    Harriet Corvol
    INSERM, UMR S U938, Paris, France
    Int J Biochem Cell Biol 41:1643-51. 2009
    ..The mechanisms underlying disease progression are discussed, with a main focus on the apoptotic pathway, the endoplasmic reticulum stress response and the developmental pathway...
  21. doi request reprint Evaluation of the trachea and intrathoracic airways by the acoustic reflection method in children with cystic fibrosis
    Nicolas Leboulanger
    UPMC University Paris 06, France
    Respir Physiol Neurobiol 181:74-8. 2012
    ..37, p=0.04). The tracheal cross-sectional area measured by the ARM is normal in children with CF but the increase in Raw during FE suggests an increase in intrathoracic airway distensibility...
  22. ncbi request reprint Circulating and airway neutrophils in cystic fibrosis display different TLR expression and responsiveness to interleukin-10
    Anne France Petit-Bertron
    Unit Cytokines and Inflammation, Institut Pasteur, 28 rue Dr Roux, 75015 Paris, France
    Cytokine 41:54-60. 2008
    ....